The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-Benzylpiperazinyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride ID: ALA1933857
PubChem CID: 14457823
Max Phase: Preclinical
Molecular Formula: C21H22ClN3O2
Molecular Weight: 347.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=C(c1cc(=O)c2ccccc2[nH]1)N1CCN(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C21H21N3O2.ClH/c25-20-14-19(22-18-9-5-4-8-17(18)20)21(26)24-12-10-23(11-13-24)15-16-6-2-1-3-7-16;/h1-9,14H,10-13,15H2,(H,22,25);1H
Standard InChI Key: XHRAKZFYNQSRMT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
15.0760 3.5813 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.5535 2.0698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5523 1.2432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2665 0.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2647 2.4822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9794 2.0735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9829 1.2411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7013 0.8302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4210 1.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4176 2.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6945 2.4949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6900 3.3190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1359 0.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1382 0.0127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8487 1.2509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5635 0.8358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2741 1.2463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2761 2.0710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5613 2.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8445 2.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9908 2.4826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7046 2.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7004 1.2445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4135 0.8314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1292 1.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1274 2.0722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4138 2.4815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 5 2 0
6 11 1 0
7 8 1 0
8 9 1 0
15 16 1 0
9 10 2 0
10 11 1 0
5 2 1 0
11 12 2 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
6 7 1 0
18 21 1 0
9 13 1 0
21 22 1 0
2 3 2 0
22 23 2 0
13 14 2 0
23 24 1 0
13 15 1 0
24 25 2 0
3 4 1 0
25 26 1 0
4 7 2 0
26 27 2 0
27 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1634AlogP: 2.49#Rotatable Bonds: 3Polar Surface Area: 56.41Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.28CX Basic pKa: 6.26CX LogP: 2.79CX LogD: 2.76Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.79Np Likeness Score: -1.07
References 1. Nagy K, Plangár I, Tuka B, Gellért L, Varga D, Demeter I, Farkas T, Kis Z, Marosi M, Zádori D, Klivényi P, Fülöp F, Szatmári I, Vécsei L, Toldi J.. (2011) Synthesis and biological effects of some kynurenic acid analogs., 19 (24): [PMID:22079867 ] [10.1016/j.bmc.2011.10.029 ]